Infinium Pharmachem Limited
NSE: INFINIUM
Infinium Pharmachem Limited is an Indian listed company, traded under NSE: INFINIUM (ISIN INE0MRE01011).
It has a market capitalisation of ₹460 crore, a last close of ₹294.90 on 2026-10-19, a one-year return of 17.6%.
Valuation: a price-to-earnings ratio of 32.36x, a price-to-book ratio of 3.80x, a dividend yield of 0.0%.
Profitability: return on equity of 12.3%, return on capital employed of 14.7%, an operating margin of 11.4%.
Balance sheet and ownership: debt-to-equity of 0.19x, promoter holding of 64.9%.
| Metric | Value |
|---|---|
| Market capitalisation | 460 |
| Last close | ₹294.90 |
| P/E (TTM) | 32.36x |
| P/B | 3.80x |
| Dividend yield | 0.0% |
| ROE (FY) | 12.3% |
| ROCE (FY) | 14.7% |
| Operating margin (TTM) | 11.4% |
| Debt / equity | 0.19x |
| Promoter holding | 64.9% |
| 1-year return | 17.6% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means